军事知识服务平台
基于空间-单细胞转录组图谱的甲状腺乳头状癌关键转录因子TBX2的鉴定及功能研究
Integrated spatial and single-cell transcriptomics identifies TBX2 as a key transcriptional regulator in papillary thyroid carcinoma
摘要 背景与目的:甲状腺乳头状癌(papillary thyroid carcinoma,PTC)是最常见的分化型甲状腺癌类型.近年来其发病率在全球范围内持续上升.尽管多数患者预后较好,但仍有部分患者出现局部侵袭、淋巴结转移及放射性碘治疗抵抗等情形,严重影响患者的长期预后.肿瘤微环境(tumor microenvironment,TME)的细胞组成及空间异质性在PTC的发生、发展中发挥重要作用,但其关键调控分子仍缺乏系统研究.单细胞转录组与空间转录组技术的有机整合,为全面解析PTC TME的细胞构成和空间特征提供了有力工具.本研究旨在整合上述两种技术,系统解析PTC TME的细胞组成和空间异质性,并筛选参与PTC进展的关键转录因子,为PTC精准诊疗提供理论依据和潜在靶点.方法:本研究整合分析了9例患者共10个甲状腺组织样本的空间转录组和单细胞转录组数据,包括9例原发性PTC组织和1例癌旁组织.采用基于典型相关分析的方法进行多样本整合,结合scType框架及甲状腺特异性标志基因完成细胞注释,并通过高变基因和空间变异基因联合筛选潜在关键转录因子.进一步 收 集 72 例 PTC 及 20 例 癌 旁 组 织 样 本,采 用 免 疫 组 织 化 学(immunohistochemistry,IHC)染色评估TBX2蛋白表达及定位情况.最后选取PTC细胞系KTC-1和TPC-1,构建TBX2稳定敲低细胞株,采用实时荧光定量聚合酶链反应(real-time fluorescence quantitative polymerase chain reaction,RTFQ-PCR)、细胞计数试剂盒-8(cell counting kit-8,CCK-8)、克隆形成、迁移及侵袭实验验证TBX2的生物学功能.结果:整合分析后成功构建了PTC TME的高分辨率细胞图谱,鉴定出肿瘤上皮细胞、滤泡细胞(follicular cell,FC)、FC2、内皮细胞、巨噬细胞、T细胞、B细胞、肿瘤相关成纤维细胞及活化型基质样细胞等9类主要细胞群.不同样本间细胞组成存在明显异质性,但整体细胞结构相对保守.进一步通过高变基因和空间变异基因联合筛选,鉴定出转录因子TBX2为潜在关键调控分子.单细胞分析显示,TBX2在肿瘤相关基质细胞尤其是肿瘤相关成纤维细胞中高表达,并在肿瘤上皮细胞中较癌旁滤泡细胞显著上调.IHC结果显示,TBX2蛋白主要定位于细胞核,PTC组织中TBX2表达水平显著高于癌旁组织(平均IHC评分:7.33 vs 0.95,P<0.000 1).功能实验结果显示,TBX2敲低后,KTC-1和TPC-1细胞中TBX2的mRNA和蛋白表达水平均显著降低,细胞增殖、克隆形成、迁移及侵袭能力均受到显著抑制.结论:本研究通过整合空间转录组与单细胞转录组数据,系统描绘了PTC TME的细胞组成及异质性特征,并鉴定出TBX2作为促进PTC进展的潜在关键转录因子.TBX2在维持PTC细胞恶性生物学行为中发挥重要作用,提示其可能成为PTC潜在的分子治疗靶点.
Abstract:
Background and purpose:Papillary thyroid carcinoma(PTC)is the most common type of differentiated thyroid cancer,with its incidence continuing to rise globally in recent years.Although the majority of patients have a relatively favorable prognosis,a subset still experiences local invasion,lymph node metastasis,and resistance to radioactive iodine therapy,which significantly impairs long-term outcomes.The cellular composition and spatial heterogeneity of the tumor microenvironment(TME)play important roles in the initiation and progression of PTC;however,the key regulatory molecules involved remain insufficiently characterized.The integration of single-cell and spatial transcriptomics provides a robust approach to comprehensively dissect the cellular composition and spatial features of the PTC tumor microenvironment.This study aims to systematically elucidate the cellular landscape and spatial heterogeneity of the PTC TME through the integration of these two technologies,and to identify key transcription factors involved in PTC progression,thereby providing a theoretical basis and potential therapeutic targets for the precision diagnosis and treatment of PTC.Methods:This study integrated and analyzed the spatial transcriptomics and single-cell transcriptomics data of 10 sequencing samples from 9 patients,comprising 9 primary tumor tissues from PTC patients and 1 adjacent non-tumor tissue.A canonical correlation analysis(CCA)-based approach was used for multi-sample integration.Cell types were annotated using the scType framework combined with thyroid-specific marker genes.Highly variable gene(HVG)and spatially variable gene(SVG)were jointly screened to identify candidate key transcription factors.In addition,immunohistochemistry(IHC)was performed on 72 PTC tissue samples and 20 adjacent normal tissues to evaluate TBX2 protein expression and cellular localization.Finally,KTC-1 and TPC-1 PTC cell lines were selected to establish stable TBX2 knockdown models.The biological functions of TBX2 were further evaluated by real-time fluorescence quantitative polymerase chain reaction(RTFQ-PCR),cell counting kit-8(CCK-8)assays,colony formation assays,and migration and invasion assays.Results:Integrated analysis generated a high-resolution cellular atlas of the PTC TME and identified nine major cell populations,including tumor epithelial cells,follicular cells(FC),FC2,endothelial cells,macrophages,T cells,B cells,cancer-associated fibroblasts and activated fibroblast-like cells.Marked inter-sample heterogeneity in cellular composition was observed,although the overall cellular architecture remained relatively conserved.Further joint screening of HVG and SVG identified TBX2 as a potential key regulatory transcription factor.Single-cell analysis showed that TBX2 was highly expressed in tumor-associated stromal cells,particularly cancer-associated fibroblasts,and was significantly upregulated in tumor epithelial cells compared with adjacent follicular cells.IHC staining revealed that TBX2 was predominantly localized in the nucleus of PTC cells.The expression level of TBX2 in PTC tissues was significantly higher than that in adjacent normal tissues(mean IHC score:7.33 vs 0.95,P<0.000 1).Functional experiments showed that TBX2 knockdown significantly reduced TBX2 mRNA and protein expression in KTC-1 and TPC-1 cells,and significantly suppressed cell proliferation,colony formation,migration and invasion.Conclusion:By integrating spatial transcriptomic and single-cell transcriptomic data,this study systematically delineated the cellular composition and heterogeneity of the PTC TME and identified TBX2 as a potential key transcription factor promoting PTC progression.TBX2 plays an important role in maintaining the malignant biological behavior of PTC cells,suggesting that it may serve as a potential therapeutic target for papillary thyroid carcinoma.
刊 名 中国癌症杂志 ISTICPKU
年,卷(期): 2026, 36(9)
分类号: R736.1
机标分类号: R736.1 S511 S792.110.4
在线出版日期: 2026年11月2日